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Mutations in the hedgehog pathway drive the forma-
tion of tumors in many different organs, including the
development of basal cell carcinoma in the skin.
However, little is known about the role of epidermal
Indian hedgehog (Ihh) in skin physiology. Using
mouse genetics, we identified overlapping and
distinct functions of Ihh in different models of
epidermal tumorigenesis. Epidermal deletion of Ihh
resulted in increased formation of benign squamous
papilloma. Strikingly, Ihh-deficient mice showed an
increase in malignant squamous cell carcinoma and
developed lung and lymph node metastases. In a
sebaceous gland tumor model, Ihh deficiency in-
hibited tumor cell differentiation. More mechanisti-
cally, IHH stimulated cell proliferation by activating
the transcription factor GLI2 in human keratinocytes
and human tumors. Thus, our results uncover impor-
tant functions for Ihh signaling in controlling prolifer-
ation, differentiation, malignant progression, and
metastasis of epithelial cancer, establishing Ihh
as a gatekeeper for controlling the grade of tumor
malignancy.
INTRODUCTION
Morphogenesis and homeostasis of mammalian tissues rely on
stringent spatiotemporal control of hedgehog (Hh) signaling
activity (McMahon et al., 2003). Indian hedgehog (Ihh) consti-
tutes one of the three mammalian ligands of the Hh family and
plays an essential role in formation and maintenance of bone
and cartilage (Lanske et al., 1996; St-Jacques et al., 1999; Chung
et al., 2001; Kobayashi et al., 2005; Maeda et al., 2007). Ihh has340 Cell Reports 4, 340–351, July 25, 2013 ª2013 The Authorsalso been shown to function in T cell development, embryo
implantation, and enterocyte differentiation (Lee et al., 2006;
van den Brink, 2007; Outram et al., 2009; Kosinski et al., 2010).
Different mutations within the Ihh coding sequences have been
identified and are mainly associated with defects in the skeleton
(Anderson et al., 2012).
In general, Hh ligands bind to the receptor patched (Ptch),
resulting in a block of Ptch-mediated repression of the Hh sig-
naling receptor smoothened (Smo). Activation of Smo induces
a cascade of signaling events that trigger changes in gene
expression by Gli transcription factors (Gli1, Gli2, and Gli3).
Many of the transcriptional targets are also important mediators
of the Hh pathway, such as Gli1, Ptch1, and the Hh interacting
protein (Hhip) (Ingham et al., 2011).
Sonic hedgehog (Shh), the most widely studied ligand of the
Hh signaling pathway, is essential for hair follicle down-growth
during early stages of hair follicle development (St-Jacques
et al., 1998; Chiang et al., 1999). Epidermal Shh stimulates the
underlying dermal papillae (DP), a structure composed of
specialized dermal cells, to signal back to neighboring keratino-
cytes and to control their proliferation and differentiation (Woo
et al., 2012). Disrupting signaling of the downstream transcrip-
tion factor Gli2 results in hair follicle arrest during early morpho-
genesis (Mill et al., 2003). This block in development is rescued in
Gli2-deficient mice by epidermal Gli2 expression, suggesting
that Hh signaling in the skin epithelium is sufficient for normal
epidermal morphogenesis (Mill et al., 2003). In adult skin, Shh in-
hibition blocks hair follicle regeneration, demonstrating its role in
hair follicle renewal during epidermal homeostasis (Wang et al.,
2000; Gritli-Linde et al., 2007). Furthermore, Hh target genes
are expressed in proliferative cells during hair follicle regenera-
tion (Oro and Higgins, 2003). Additionally, Gli1 expressing stem
cells of the hair follicle bulge have been identified to respond
to Shh produced by neurons in the adult tissue (Brownell et al.,
2011). More mechanistically, Shh signals via Gli transcription
factors to activate Brg1 in bulge stem cells to initiate hair regen-
eration. Subsequently, Brg1 recruits nuclear factor kB (NF-kB) to
induce Shh to sustain proliferation in matrix cells, thereby
generating a positive feedback loop for hair follicle regeneration
(Xiong et al., 2013). Collectively, these data indicate that Hh
signaling plays crucial roles in both epidermal morphogenesis
and homeostasis.
It is well established that uncontrolled activation of Hh sig-
naling results in the development of cancer in different organs,
including brain, muscle, and skin (Pasca di Magliano and
Hebrok, 2003; Teglund and Toftga˚rd, 2010; Ng and Curran,
2011). Therefore, to design effective therapies, it is important
to gain a detailed molecular understanding of Hh signaling and
identify activating mutations. Mutations in the Ptch1 receptor
are found in patients with basal cell nevus syndrome (BCNS,
also known as Gorlin-Goltz syndrome), which is characterized
by a high incidence of medulloblastoma and basal cell carci-
noma (BCC). Additionally, Ptch1 mutations have been identified
in a subset of sporadic BCC (Teglund and Toftga˚rd, 2010).
Whether mutations in other Hh pathway components contribute
to Hh-driven skin cancer has not been sufficiently investigated.
Previously, we and others (Niemann et al., 2003; Takeda et al.,
2006; Lo Celso et al., 2008) detected expression of Ihh in human
sebaceous skin tumors and human sebocyte cell lines. However,
the functional relevance of Ihh signaling in skin physiology and
skin cancer is unknown.
The aim of this study was to unravel the role of Ihh in epidermal
development and tumorigenesis. We investigated the specific
function of epidermis-derived Ihh by deleting Ihh in mouse
epidermis and identified a critical gatekeeper function of Ihh
in skin cancer metastasis. Furthermore, we studied the role of
individual Gli transcription factors in different types of skin
tumors and unraveled an important role for Gli2 in mediating
the effects of Ihh. Our findings also point to nonoverlapping
signaling activities of Ptch1-dependent Hh signaling and Ihh in
skin cancer.
RESULTS
Ihh Controls Differentiation and Progenitor Marker
Expression in Sebaceous Skin Tumors
To investigate the function of Ihh in mammalian epidermis, we
generated mice with a conditional epidermal deletion of Ihh
(thereafter IhhEKO) by crossing Ihhfl/fl mice with keratin 14-Cre
animals (K14Cre) (Hafner et al., 2004; Razzaque et al., 2005).
K14Cre is active from embryonic day 13 onward in basal kerati-
nocytes, leading to Ihh deletion in all epithelial compartments,
including the interfollicular epidermis, hair follicles, and seba-
ceous glands (Figure 1A). In mouse epidermis, expression of
Ihh is closely associated with hair follicle morphogenesis and
its temporal regulation is similar to that of Shh and Ptch1 (Figures
S1A–S1C). Although the overall expression level of Ihh in
epidermis is low, the strongest expression of Ihh messenger
RNA (mRNA) is detected in the epidermis of adult mice (Fig-
ure S1C). In particular, Ihh mRNA expression was detected in
the Lrig1+ve (both integrina6high and integrina6low) sebaceous
gland progenitor compartment of adult mouse epidermis (Fig-
ure 1D; Jensen et al., 2009). Interestingly, a correlation between
Lrig1 and Ihh expression was also detected in sebaceous skin
tumor cells (Figures S1F and S1G).As expected, the epidermis and primary keratinocytes of
newborn IhhEKO mice showed efficient Cre recombination (Fig-
ure 1B), and no Ihh expression was detected at postnatal day
2 (P2; Figure 1C) and P7 in IhhEKO mice (Figure S1E). IhhEKO
mice were viable and showed no macroscopic skin phenotype.
Histological analysis revealed that hair follicles and sebaceous
glands appeared normal in IhhEKO mice compared with control
littermates (Figures 1E and S1D). To examine whether Shh
expression is regulated to potentially compensate for Ihh loss
in mouse epidermis, we determined the expression levels of
Shh in P2 epidermis of IhhEKO and Ihhfl/fl control mice. No signif-
icant changes were detected in Shh or Ptch1 receptor expres-
sion in Ihh-deficient epidermis (Figures 1F and 1G), indicating
that either Ihh is dispensable for epidermal morphogenesis or
normal Shh expression is sufficient to take over Ihh functions in
IhhEKO mice.
The fact that Hh and the receptor Ptch1 are associated with
the sebaceous gland cell lineage is further supported by data
demonstrating that Ihh is a direct target of c-myc, an important
regulator of sebocyte lineage differentiation (Takeda et al., 2006;
Lo Celso et al., 2008). Furthermore, Hh activity was strongly
increased in cell lines established from individual sebaceous tu-
mors compared with normal primary keratinocytes (Figure S2E).
To investigate whether Ihh has a function in sebaceous tumor
formation, IhhEKO mice were crossed with K14DNLef1 trans-
genic mice (Niemann et al., 2002). In this mouse model, topical
treatment with a single subthreshold dose of the carcinogen
7,12-dimethylbenz[a]anthracene (DMBA) induces the formation
of sebaceous skin tumors with high frequency (Niemann et al.,
2007; Figure 2A). No Ihh expression was detected in sebaceous
tumors generated in IhhEKO mice (Figure 2G). In control mice,
expression of Ihh is rather low, indicating that only a subpopu-
lation of tumor cells produces this Hh ligand (Figure 2G). The
incidence of sebaceous tumors was not altered upon deletion
of Ihh from epidermis and the frequency of tumors was not
significantly reduced in IhhEKO mice (Figures 2B and 2C).
However, major differences were observed in tumor histology
and differentiation of tumor cells. K14DNLef1/Ihhfl/fl control
mice developed well-differentiated sebaceous adenoma typi-
cally consisting of multiple tumor lobules (sl), with each lobule
featuring a layer of basal germinative epithelial cells at the
periphery and mature sebocytes in the inner compartment of
the lobule (Figure 2D). In contrast, the lobular structure of the
IhhEKO tumors was significantly altered and the number of
mature sebocytes was dramatically reduced (Figure 2D, s).
Instead, tumors generated in IhhEKO mice frequently displayed
a reticular morphology that was not observed in tumors of con-
trol mice (Figure 2D). A detailed analysis of cell differentiation
within the tumors further strengthened this observation. Expres-
sion of the sebocyte marker stearoyl coenzyme A desaturase 1
(SCD1) was strongly reduced and the disturbed lobular archi-
tecture of sebaceous tumors was highlighted by the abnormal
distribution of the sebaceous duct marker keratin 6a (K6a) and
squamous differentiation marker keratin 10 (K10) in IhhEKO
mice (Figures 2D and 2E). These data demonstrate that Ihh
signaling is dispensable for initiating sebaceous tumors but
is crucial for governing the sebocyte differentiation program of
tumor cells.Cell Reports 4, 340–351, July 25, 2013 ª2013 The Authors 341
Figure 1. Epidermal Morphogenesis and
Homeostasis in IhhEKO Mice
(A) Schematic depiction of different compartments
of mammalian epidermis. The K14 promoter (K14,
red) is active in basal keratinocytes of the inter-
follicular epidermis, hair follicle, and sebaceous
gland.
(B) PCR analysis of genomic DNA isolated for
floxed (1.2 kb) and deleted (400 bp) Ihh allele from
epidermis of Ihhfl/fl () and IhhEKO (+) mice (n = 3).
(C) qRT-PCR for Ihh mRNA expression in P2
mouse epidermis of IhhEKO (+) and Ihhfl/fl con-
trol mice (). PCR results are presented as
mean ± SD.
(D) Ihh mRNA expression in Lrig1- and integrina6-
sorted (Itga6) keratinocytes from adult mice, as
determined by qRT-PCR (n = 2). PCR results are
shown as mean ± SD.
(E) Histology (hematoxylin and eosin [H&E]) and
immunostaining for expression of sebocyte dif-
ferentiation marker adipophilin (Adipo) in skin
sections of 7-week-old IhhEKO mice (n = 7) and
Ihhfl/fl control mice (n = 5). Scale bars, 50 mm.
(F and G) qRT-PCR for Ptch1 (F) and Shh (G)
mRNA expression in P2 mouse epidermis of
IhhEKO (+) and Ihhfl/fl control mice (). PCR results
are shown as mean ± SD.
See also Figure S1.Next, we wanted to know whether sebaceous gland and
squamous differentiation is also altered in the skin of IhhEKO
mice. Therefore, we compared the expression of marker mole-
cules in skin from P2 and adult IhhEKO and control mice.
Expression of both the sebaceous gland marker adipophilin
(Figures 1E and S2A) and SCD1 (Figure S2B) was not affected
upon epidermal Ihh deletion. In addition, the sebaceous
glands developed normally, as seen in epidermal whole mounts
of P2 and P9 IhhEKO mice (Figures S1D and S2B). The expres-
sion pattern for K10 and filaggrin, marker molecules for squa-
mous differentiation of keratinocytes, was also not disturbed
in IhhEKO P2 and adult skin (Figures S2C and S2D). We
conclude that abnormal differentiation is specific to pathophys-
iological conditions (e.g., sebaceous skin tumors in IhhEKO
mice), but is not detected during normal epidermal develop-
ment and homeostasis in adult skin upon epidermal Ihh
deletion.342 Cell Reports 4, 340–351, July 25, 2013 ª2013 The AuthorsTo investigate whether the observed
alterations in tumor morphology and dif-
ferentiation could result from differences
in the distribution and number of hair folli-
cle stem and progenitor cells within the
tumors, we examined the expression of
the sebaceous lineage-associated pro-
genitor marker Plet1 (Nijhof et al., 2006;
Raymond et al., 2010). Remarkably, cells
found in reticular structures of IhhEKO
tumors were strongly positive for Plet1,
whereas only a few Plet1-positive cells
were found in control tumors (Figure 2D).
An increase in Plet1 was also detected inprotein lysates of tumors generated in IhhEKO mice compared
with sebaceous tumors in Ihhfl/fl mice (Figure 2F), suggesting
that loss of mature sebocytes could be a direct consequence of
the inhibition of precursor cell differentiation.
Ihh Deficiency Does Not Affect Stem Cell Function
during Skin Homeostasis
Given the important function of Shh and Gli1 in hair follicle bulge
stem cells (Brownell et al., 2011; Xiong et al., 2013) and the regu-
lation of the progenitor marker Plet1 in sebaceous tumors devel-
oping in IhhEKO mice, we wanted to know whether normal stem
cell function is generally affected upon Ihh deletion from mouse
epidermis. To address this important issue, we analyzed distinct
stem cell and progenitor compartments of the pilosebaceous
unit in great detail. The bulge stem cell marker Sox9, keratin 15
(K15), and CD34 were not changed in IhhEKO mice (Figures 3A,
S3A, and S3B). Moreover, the number of CD34+/integrina6high
Figure 2. Ihh Deletion from Mouse
Epidermis Leads to Impaired Differentiation
of Sebaceous Skin Tumors
(A) Experimental layout for sebaceous tumor ex-
periments performed in K14DNLef1 mice.
(B and C) Incidence (B) and frequency (C) of
sebaceous tumors in K14DNLef1/IhhEKO (n = 19)
and K14DNLef1/Ihhfl/fl mice (n = 17). Two-way
ANOVA with repeated measures for ± SEM.
(D) Histology (H&E) and immunostaining for
expression of differentiation marker SCD1, K10,
and progenitor marker Plet1 (all in green) in tumors
of K14DNLef1/IhhEKO and K14DNLef1/Ihhfl/fl mice
(n = 25). sl, sebaceous lobules; s, sebocytes. Scale
bars, 100 mm.
(E and F) Western blot analysis for sebocyte dif-
ferentiation marker SCD1 and a-Tubulin (loading
control) (E), and Plet1 and GapDH (loading control)
(F) in lysates of sebaceous tumors formed in Ihhfl/fl
and IhhEKO mice.
(G) qRT-PCR for Ihh mRNA expression in seba-
ceous tumors generated in IhhEKO and Ihhfl/fl con-
trol mice. PCR results are shown as mean ± SD.
See also Figure S2.stem cells, as well as the location and number of label-retaining
cells (LRCs) of the hair follicle bulge, was not altered in adult mice
upon Ihh deletion (Figures 3B and 3C). Next, we examined the
expression of Lrig1 and Plet1, markers for hair follicle stem and
progenitor cells that are associated with Ihh function in seba-
ceous tumors (Figures 1D, 2D, and 2F). Both markers showed
a normal expression pattern in P3 and 7-week-old IhhEKO mice
compared with littermate controls (Figures 3D and 3E). Thus,
Plet1 marker expression and localization are specifically altered
in the sebaceous tumor model, but not in normal skin in IhhEKO
mice.
Finally, we tested for the physiological function of epidermal
stem cells and the sebaceous gland. Measurements of transepi-
dermal water loss (TEWL) revealed that there was no inside-outCell Reports 4, 340–barrier defect in IhhEKO newborn mice
(Figure S3C). In addition, we analyzed
the production of sebaceous gland lipids
and epidermal lipids of the stratum cor-
neum. These assays demonstrated that
lipid production was not affected and
that crucial functionsof theepidermal bar-
rier and the sebaceous glands were not
disturbed in IhhEKO mice (Figures S3D
and S3E). Thus, we conclude that Ihh
signaling regulates progenitor function in
sebaceous tumors, but is not crucial for
stem cell function and homeostasis of
the pilosebaceous unit.
IhhDeficiency Promotes Squamous
Skin Tumor Formation
Because our results showed that Ihh
plays an important role in differentiation
of sebaceous tumor cells, we sought toaddress whether this function also applies to epidermal cancer
in general. To that end, we induced squamous skin tumors in
IhhEKO mice using the two-stage chemical skin carcinogenesis
protocol. This protocol involves the topical application of
DMBA, leading to oncogenic Ras mutations, followed by repet-
itive treatment with the tumor promoter 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), resulting in the proliferation of initiated
cells (Figure 4A; DiGiovanni, 1992). Typically, this leads to the
formation of benign papillomas that may eventually progress to
malignant SCCs. Interestingly, and in contrast to the sebaceous
tumor model, IhhEKO mice developed more papillomas and the
incidence of squamous tumors was increased upon epidermal
deletion of Ihh (Figures 4B and 4C). Initially, the papillomas
grewmore slowly in IhhEKOmice (Figure 4D). These data indicate351, July 25, 2013 ª2013 The Authors 343
Figure 3. Stem Cell Function Is Not Affected in IhhEKO Mice
(A and B) Immunostaining for (A) the hair follicle bulge stem cell marker Sox9
(green) in a skin section, and (B) LRC (green) andK14 (red) in anepidermalwhole
mount from adult Ihhfl/fl (n = 5) and IhhEKO mice (n = 7; LRC: n = 3). B, bulge.
(C) Representative fluorescence-activated cell sorting plot and quantification
for CD34+/integrina6high (CD49f) keratinocytes from 7-week-old Ihhfl/fl and
IhhEKO mice (n = 2).
(D and E) Immunostaining for the progenitor marker molecules Lrig1 (D) and
Plet1 (E; both green) in skin sections of P3 (n = 5) and 7-week-old (n = 3) Ihhfl/fl
and IhhEKO mice. I, isthmus; JZ, junctional zone.
Scale bars, 50 mm (A and D), 100 mm (B), and 20 mm (E). See also Figure S3.that Ihh suppresses the formation of squamous tumors, but once
tumor growth is initiated, it stimulates the proliferation of tumor
cells, resulting in increased tumor mass. In addition, squamous
differentiation of keratinocytes was also altered in the papillomas
of IhhEKO mice. Particularly, the expression of differentiation
marker K10 was strongly reduced, demonstrating a block in
squamous differentiation in the absence of epidermal Ihh (Fig-
ure 4F). In contrast, expression of the basal keratinocyte marker
K5 was not dramatically altered in different tumors generated in
IhhEKO mice (Figures S4A–S4C). Together, our results unravel a
novel function of Ihh in governing cellular differentiation pro-
grams in different tumor types, including sebaceous and squa-
mous skin tumors.
Increase in Malignant Tumor Progression and
Metastasis in Ihh-Deficient Mice
To investigate whether Ihh is important for the progression of
benign papillomas to malignant SCCs, we monitored the mice
for up to 50 weeks following DMBA treatment. Surprisingly,344 Cell Reports 4, 340–351, July 25, 2013 ª2013 The Authorsepidermal deletion of Ihh resulted in a strong increase in SCC
formation, with significantly more mice displaying malignant
tumors and an increased number of papillomas progressing to
SCC (Figures 4B, 4E, and 5A). SCC developed slightly later in
IhhEKO mice (25 weeks in Ihhfl/fl versus 28 weeks in IhhEKO after
DMBA treatment), but once the progression of benign papil-
lomas to malignant SCCs began, this process proceeded
much more rapidly in Ihh-deficient epidermis compared with
controls (Figure 4B). At the end of the two-stage chemical
carcinogenesis experiment, IhhEKO mice displayed significantly
fewer benign squamous papillomas and keratoacanthomas
than Ihhfl/fl control mice, whereas the number of SCCs was
strongly increased (Figure 4E). Expression analysis revealed
that Ihh was not detected in papillomas and SCCs formed in
IhhEKO mice. Papillomas and SCCs of control mice showed
variable but low expression of Ihh, indicating that only a subpop-
ulation of tumor cells produced the ligand (Figure 5G). Of note, no
upregulation of Shh RNA expression and no significant changes
in Ptch1 expression were detected in tumors of IhhEKO mice
(Figure S5).
Importantly, phenotypic differences were observed between
SCCs from IhhEKO and control mice. While SCCs from control
mice grew in defined epithelial tumor cell clusters that often
seemed to be separated from the surrounding stromal tissue,
SCCs of IhhEKO mice frequently exhibited a dispersed and inva-
sive pattern of tumor growth, and some SCCs even resembled
spindle cell carcinoma (SpCC; Figures 5B and 5C). Such aggres-
sive tumors were not formed in control mice. Staining for the
a-5 subunit of laminin revealed disruption of the basement
membrane between the stromal and epithelial cells of SpCC in
Ihh-deficient mice (Figure 5C). In agreement with the histological
features of aggressive growth and poor differentiation, mitotic
figures and abnormal nuclei were common to SCCs of IhhEKO
mice (inset, Figure 5B). Moreover, we observed suprabasal
integrina6 expression in SCCs from IhhEKO mice. In contrast,
integrina6 was localized to the basement membrane and
basal compartment of SCCs in control mice (Figure 5D). Given
that suprabasal expression of a6b4 integrins is a hallmark of
epidermal neoplastic progression, our data clearly demonstrate
an increase in malignancy upon epidermal Ihh deletion (Tennen-
baum et al., 1993; Van Waes et al., 1995).
Strikingly, our analysis of tumor-bearing mice disclosed the
presence of metastasis in Ihh-deficient mice but not in control
animals. Of note, mice in a C57BL/6 background are normally
extremely resistant to malignant conversion and formation of
metastasis. Metastases were identified in lymph nodes (Fig-
ure 5E) and in the lung of IhhEKO mice (Figure 5F). Abundant
immunofluorescent staining with antibodies against K14, a
marker for undifferentiated keratinocytes, confirmed the pres-
ence of epidermis-derived cells in metastases (Figures 5E and
5F). These results show that epidermal Ihh not only inhibits the
formation of papillomas but, importantly, also blocks the malig-
nant progression of benign squamous tumors and the develop-
ment of metastasis.
To investigate the mechanism of the increased metastatic
behavior, we examined the potential role of Ihh in keratinocyte
migration. For this purpose, we isolated primary keratinocytes
from IhhEKO and control mice, and analyzed the migration of
Figure 4. Loss of Ihh from Mouse Epi-
dermis Promotes Ras-Mediated Skin
Cancer and Alters Proliferation and Tumor
Differentiation
(A) Experimental layout for two-stage chemical-
induced carcinogenesis studies.
(B and C) Incidence (B) and frequency (C) of
squamous tumors developing in Ihhfl/fl (n = 19)
and IhhEKO (n = 20) mice. Treatments in control
groups (n = 14 per genotype) did not result in
papillomas.
(D) Quantification of tumor size for papillomas and
SCCs in Ihhfl/fl and IhhEKO mice (at weeks 41 and
50 after tumor initiation). Results are presented as
mean ± SEM. *p < 0.05; p = 0.057 (pap week 50)
and p = 0.580 (SCC week 50).
(E) Incidence of papilloma and keratoacanthoma
(Pap/KA) and SCC in Ihhfl/fl (n = 26) and IhhEKO (n =
28) mice at the end of one representative experi-
ment. Note that only tumors that could be clearly
categorized based on histological appearance are
presented.
(F) Histology (H&E) and immunostaining for keratin
10 (K10, green) in papillomas of IhhEKO and Ihhfl/fl
mice (n = 9). Scale bars, 100 mm.
See also Figure S4.primary cells in vitro. Interestingly, Ihh-deficient keratinocytes
migrated significantly faster than control cells (Figure 5H).
Thus, our data indicate that Ihh blocks metastasis by inhibiting
the migration of keratinocytes, thereby preventing keratinocytes
from leaving the primary tumor.
Ihh Regulates Cell Proliferation in Mammalian
Epidermis and Different Types of Skin Tumors
Given the reduced size of papillomas developing in IhhEKO mice,
we investigated the involvement of Ihh in regulating proliferation.
To this end, we analyzed bromodeoxyuridine (BrdU) incorpora-
tion in epidermal tumors generated in the different mouse
models. Interestingly, the number of BrdU positive keratinocytes
was >2-fold reduced in papillomas developing in IhhEKO mice
compared with controls (Figure 6A). In addition, Ihh-deficient
mice showed less cell proliferation in SCC (Figure 6B) and a
strong reduction in proliferation sebaceous tumors generated
in the K14DNLef1 background (Figure 6C). Moreover, cell prolif-Cell Reports 4, 340–eration was also suppressed in primary
keratinocytes isolated from IhhEKO mice
and in hair follicles of newborn Ihh-
deficient mice compared with control
animals (Figures 6D and S6A). This
reduced proliferation rate was observed
until P3. At this time of development,
Shh mRNA expression normally is
detected in hair follicle keratinocytes,
and potentially could compensate for
this defect seen in Ihh-deficient epi-
dermis from P3 onward (St-Jacques
et al., 1998; Figure S1B). Taken together,
our results reveal that Ihh stimulates pro-liferation during epidermal morphogenesis and promotes growth
in various types of skin tumors.
Ihh Controls Cell Proliferation by Activating GLI2
Signaling
Our data clearly demonstrate that Ihh plays an important role in
regulating tumor cell proliferation and malignant conversion. To
investigate the molecular mechanism of this effect in human
epidermal cells and human skin tumors, we analyzed the func-
tion of GLI transcription factors in this process. In general, the
transcriptional effectors responsible for mediating Ihh functions
are not well understood and most likely are dependent on the
cell type and the microenvironment (Joeng and Long, 2009).
First, we studied the functions of the individual GLI proteins
in vitro using the sebaceous gland cell line SZ95 (Zouboulis
et al., 1999; Niemann et al., 2003). The expression of key compo-
nents of the HH pathway was low in undifferentiated sebocytes
but strongly increased when proliferation or differentiation was351, July 25, 2013 ª2013 The Authors 345
Figure 5. Epidermal Deletion of Ihh Pro-
motes Malignant Tumor Progression and
Tumor Metastasis
(A) Number of papillomas progressing to malig-
nant SCC in Ihhfl/fl (n = 19) and IhhEKOmice (n = 20).
Quantification of a representative experiment.
(B) Histology (H&E) of SCC and mitotic figures
(arrows) and abnormal nuclei (insets) of repre-
sentative tumors developing in Ihhfl/fl and IhhEKO
mice.
(C) Histology (H&E) and immunostaining for lami-
nin (green) and nuclei (magenta) of SpCC devel-
oping in IhhEKO mice. Note disruption of basement
membrane staining (arrows).
(D) Immunostaining for integrina6 (Itga6; green) in
SCC of Ihhfl/fl (n = 3) and IhhEKO mice (n = 8).
(E and F) Macroscopic view, histology (H&E), and
immunostaining for K14 (green) of metastases in
lymph nodes (E) and lung (F) observed in IhhEKO
and Ihhfl/fl control mice.
(G) qRT-PCR for Ihh mRNA expression in benign
papillomas and malignant SCCs generated in
IhhEKO and Ihhfl/fl control mice. PCR results are
presented as mean ± SD.
(H) Representative images of scratch assay (18 hr)
and quantification of the migration of primary
keratinocytes isolated from Ihhfl/fl and IhhEKO mice
(n = 3). Areas are presented as mean ± SD. *p <
0.05, ***p < 0.001.
Scale bars, 100 mm (B–D), 50 mm (E and F), and
20 mm (inset in B). See also Figure S5.induced (Figure S6B). Importantly, IHH was the only HH ligand
that was highly expressed by mature SZ95 sebocytes, and
expression of SHH and DHH was not detected in sebaceous
gland cells (Figure 6B; data not shown). This observation further
strengthens our initial finding that Ihh signaling directs the seba-
ceous gland fate in tumors of K14DNLef1 mice (Figures 2D and
S6B). In addition, the fact that only IHH was expressed made
this cell line an ideal model for specific molecular dissection of
IHH signaling. In line with the expression data, HH activity was
strongly increased in mature sebocytes, as assessed by the
activity of a Gli reporter construct (Figure 6E). Remarkably,
GLI2 and GLI3, but not GLI1, were highly expressed in SZ95
cells, suggesting that these twomolecules govern sebocyte pro-
liferation and differentiation, and thatGLI1 is not a target gene of
HH activity in sebocytes (Figure S6B; data not shown).
Next, we studied the effect of individual GLI transcription fac-
tors on cell proliferation by overexpressing them in undifferenti-
ated sebocytes. Interestingly, GLI2 strongly increased BrdU346 Cell Reports 4, 340–351, July 25, 2013 ª2013 The Authorsincorporation (Figure 6F), indicating that
GLI2 could be transmitting the effect
of IHH on proliferation in mammalian
epidermis and different types of skin
tumors. To test this hypothesis, we trans-
fected primary keratinocytes isolated
form IhhEKO and control mice with an
expression vector for Gli2. Indeed, Gli2
expression was sufficient to rescue the
proliferation defect in IhhEKO keratino-cytes (Figure 6H), identifying this transcription factor as a crucial
mediator of Ihh function in cell proliferation.
To further confirm that GLI signaling indeed regulates kerati-
nocyte proliferation, we treated SZ95 sebocytes with Gant61,
a small-molecule inhibitor of the HH-GLI signaling axis that
interferes with DNA binding of GLI transcription factors
(Lauth et al., 2007). Treatment of SZ95 cells with Gant61 led
to a strong reduction of BrdU incorporation in a dose-depen-
dent manner (Figure 6G), showing that GLI2 is an important
regulator of proliferation in mammalian epidermis and skin
tumors. In addition, a similar result was also observed with
cyclopamine, an inhibitor of the Hh coreceptor Smo (Fig-
ure 6G). Remarkably, growth of sebaceous tumors generated
in K14DNLef1 mice was blocked following treatment with
cyclopamine (Figure S6C). Thus, these data indicate that block-
ing of Ihh and Gli2 signaling is a potential therapeutic strategy
for treating sebaceous gland cell hyperproliferation in mamma-
lian skin.
Figure 6. GLI2 Mediates Ihh-Driven Regula-
tion of Proliferation
(A–C) Immunostaining for BrdU (green), K14 (red),
and DAPI (blue), and quantification of BrdU+ve
keratinocytes in squamous papilloma (A; n = 6),
SCC (B; n = 3), and sebaceous skin tumors (C; n =
20) in Ihhfl/fl and IhhEKO mice. Quantification is
shown as mean ± SD. *p < 0.05, ***p < 0.001.
Scale bars: 100 mm (A and C) and 50 mm (B).
(D) Quantification of BrdU incorporation into pri-
mary keratinocytes isolated from newborn Ihhfl/fl
and IhhEKO mice (n = 3). Quantification is shown as
mean ± SD. ***p < 0.001.
(E) Gli reporter gene activity tested with Gli-BS-
luciferase (light gray; mutant Gli-binding sites as
control in dark gray) in undifferentiated und
differentiated SZ95 human sebocytes (n = 3). Fold
change is presented as mean ± SD.
(F) Quantification of BrdU incorporation into
human SZ95 sebocytes following transfection
with Gli expression constructs. Fold change over
mock-transfected cells is presented as mean ±
SD. **p < 0.01, ***p < 0.001.
(G) Quantification of BrdU-positive SZ95 sebo-
cytes following treatment with increasing con-
centrations of cyclopamine (5, 10, and 50 mM) and
GANT61 (10, 50, and 100 mM). Numbers are
presented as mean ± SD. *p < 0.05, **p < 0.01,
***p < 0.001.
(H) Quantification of BrdU incorporation into pri-
mary keratinocytes isolated from newborn Ihhfl/fl
and IhhEKO mice (n = 2) following transfection with
Gli expression constructs (n = 3). Fold change is
presented as mean ± SD.
See also Figure S6.Finally, we tested whether GLI transcription factor expression
and IHH signaling are also altered in human sebaceous tumors.
To that end, we analyzed mRNA expression of GLI1,GLI2,GLI3,
and PTCH1 in human sebaceous tumors and normal skin by
quantitative RT-PCR (qRT-PCR). Interestingly, GLI1 was ex-
pressed in normal skin but was almost absent from tumor sam-
ples (Figure 7A), and mRNA levels for GLI3 were low in tumors,
which suggests that these two GLI proteins do not play a crucial
role in this particular type of tumor. In contrast,GLI2was strongly
expressed in differentiated and undifferentiated human seba-Cell Reports 4, 340–ceous tumors compared with human
SCCs, pointing to an important role of
this transcription factor in mediating the
IHH effect on proliferation in human seba-
ceous skin tumors (Figure 7B). The recep-
tor PTCH1 was strongly expressed in
human sebaceous tumors compared
with normal skin (Figure 7A). Given that
PTCH1 is also an HH target gene, this
result further strengthens our initial
observation that IHH signaling is impor-
tant for driving the proliferation and differ-
entiation of sebaceous tumors.
Taken together, our experimental data
clearly demonstrate a function for Ihh inregulating proliferation and differentiation in different pathophys-
iological settings. We provide evidence that the transcription
factor Gli2 plays a central role in mediating these effects. Finally,
epidermal Ihh is essential for protecting against malignant pro-
gression and metastasis of epidermal tumors (Figure 7C).
DISCUSSION
Activation of the Hh signaling cascade has been linked to several
human cancers, and changes in Hh activity are commonly linked351, July 25, 2013 ª2013 The Authors 347
Figure 7. Hh Signaling in Human Sebaceous
Tumors and SCCs
(A and B) qRT-PCR for expression of PTCH1,
GLI1, and GLI3 (A) and Gli2 (B) in human seba-
ceous tumors (A and B), human SCCs (B), and
normal human skin.
(C) Model for specific functions of Ihh in regulating
epidermal homeostasis and skin tumorigenesis.to mutations in components of the pathway (Pasca di Magliano
and Hebrok, 2003; Scales and de Sauvage, 2009). In addition,
ligand-dependent cancers have been proposed to result from
an autocrine or paracrine signaling response. Here, we identified
in vivo functions for Ihh in mammalian skin tumors. Ihh stimulates
cell proliferation in different experimental settings and is required
for sebocyte differentiation in a mutant Lef1-induced sebaceous
tumor model. Most strikingly, Ihh blocks the progression of
benign papillomas to malignant SCCs and prevents metastasis
of SCCs in a Ras-driven skin tumor model. These results unravel
crucial functions for Ihh in epithelial cancer and clearly demon-
strate that Ihh is required beyond its function in morphogenesis
and normal tissue homeostasis.
Generally, abnormal activation of Hh signaling is strongly
associated with tumor initiation and maintenance of tumor
growth (Pasca di Magliano and Hebrok, 2003). Remarkably, we
observed that Ihh blocks tumor initiation, progression, and
metastasis of SCCs. This points to diverse functions of Hh
signaling in skin cancer, and strongly suggests that Shh and
Ihh play different roles in this process. In line with our results, a
similar function for Ihh in tumor cell differentiation and concom-
itant repression of progenitor cell proliferation was observed in
colon cancer (van den Brink et al., 2004; van den Brink, 2007;
Fu et al., 2010). In this model, Ihh expression strongly correlated
with the grade of malignancy, with the highest Ihh expression
levels observed in differentiated intestinal tumors. In contrast,
strong expression of Shh was detected in undifferentiated malig-
nancies (van den Brink, 2007; Saqui-Salces and Merchant,
2010), further supporting the notion that these two Hh ligands
play opposing roles. Notably, specific and nonoverlapping func-
tions for these Hh ligands have also been proposed to govern tis-
sue homeostasis in the intestine and skin, where expression of
both factors is restricted to a distinct compartment within the
tissue. In the intestine, Shh is expressed in crypts where it is348 Cell Reports 4, 340–351, July 25, 2013 ª2013 The Authorsassociated with proliferation, whereas
Ihh promotes differentiation in the villi
(van den Brink, 2007). Likewise, Shh reg-
ulates hair growth in the lower hair follicle
of the skin, whereas Ihh has been pro-
posed to affect differentiation in seba-
ceous gland cells (Niemann et al., 2003;
Lo Celso et al., 2008).
A central finding of our study is that
epidermal deletion of Ihh leads to
reduced proliferation during epidermal
development in newborn mice as well as
in both sebaceous and squamous skin
tumor models. This clearly points to ageneral role of Ihh activity in keratinocyte proliferation. Surpris-
ingly, although keratinocyte proliferation was strongly sup-
pressed in IhhEKO during early postnatal stages of epidermal
development, hair follicle morphogenesis was not arrested as
seen in Shh/ and Gli2i/ mice (St-Jacques et al., 1999; Mill
et al., 2003). The morphology of DP appears normal in IhhEKO
mice, and despite a temporary decrease in cell-cycle progres-
sion, no impact on hair follicle morphogenesis is observed. Our
data therefore demonstrate that Ihh does not regulate DP func-
tion to the same extent as Shh (Woo et al., 2012). Alternatively,
Shh and potentially Dhh (produced by the DP cells) (Brownell
et al., 2011; Xiong et al., 2013) could compensate for the loss
of epidermal Ihh.
Remarkably, although keratinocyte proliferation is strongly
reduced, malignant progression, cell migration, and metastasis
are induced upon epidermal deletion of Ihh. Generally, the high
proliferation rate of tumor cells constitutes an important prereq-
uisite to allow for further accumulation of mutations leading to
expansion of more aggressive tumor cell clones. Our data
demonstrate that Ihh plays a dominant gatekeeper role in block-
ing the progression and expansion of malignant tumor cell pop-
ulations. Interestingly, human BCC, an HH-driven skin cancer,
rarely metastasizes. Our results raise the question as to whether
HH signaling plays a general role in suppressing the migration
of keratinocytes and metastasis of epidermal cancers despite
promoting their proliferation. This may involve a mechanism
whereby HH stimulates the proliferation of a subpopulation of
more differentiated and immobile tumor cells that are incapable
of malignant progression and metastatic spread. This idea is
further supported by our finding that the pool of Plet1-expressing
progenitor cells was increased in tumors upon epidermal Ihh
deletion.
Mechanistically, we observe that Ihh exerts its effect on
proliferation mainly by activating the transcription factor Gli2.
Importantly, Gli2 expression can rescue the proliferation defect
in IhhEKO keratinocytes. A strong increase in GLI2 and GLI3
expression is seen during proliferation and differentiation of
SZ95 human sebocytes, whereas GLI1 does not seem to play
a role in these cells. Because IHH is the only Hh ligand expressed
by SZ95 sebocyte cells and HH activity is strongly increased
upon differentiation of these human cells, we conclude that
IHH is important for balancing the proliferation and maturation
of epidermal cells during skin homeostasis and under patho-
physiological conditions. It was recently shown that the inhibition
of HH signaling at the level of GLI transcription factors sup-
presses the growth of neuroblastoma (Wickstro¨m et al., 2012),
further strengthening our conclusion that GLI2 is indeed a rele-
vant therapeutic target for other types of tumors.
Our results identify overlapping but also diverse functions of
Ihh in two different models for epidermal tumorigenesis.
Whereas epidermal deletion of Ihh does not influence tumor
development in mutant Lef1-induced sebaceous tumors, it pro-
motes the incidence, frequency, and malignant progression of
Ras-driven squamous skin cancer. This highlights the tremen-
dous impact the type of oncogenicmutation and cellular environ-
ment has on driving the development of a particular type of
tumor. Indeed, an important role for a crosstalk between Hh
and EGFR/Ras signaling has been shown for various tumor
models (Mangelberger et al., 2012). Furthermore, the cell of
origin could differ between sebaceous and squamous skin
cancers and subsequently lead to distinct Hh responses. Given
our finding that Ihh activity in skin tumor formation is context
dependent, our work emphasizes the need for a more detailed
analysis of HH components and activity in human cancer and
points to novel experimental strategies for designing personal-
ized therapies (Atwood et al., 2012).
Together, our results identify specific functions for Ihh in
different types of skin tumors. Ihh stimulates differentiation and
proliferation, and protects against malignant progression, migra-
tion, and metastasis of squamous skin cancer.
EXPERIMENTAL PROCEDURES
Experimental Mice and Tumor Tissues
To generate epidermis-specific deletion of Ihh (IhhEKO), mice carrying a condi-
tional Ihh allele (Razzaque et al., 2005) were crossed with K14Cre mice (Hafner
et al., 2004). For sebaceous tumor studies, IhhEKO mice were crossed with
K14DNLef1 transgenics (Niemann et al., 2002). All mouse strains had been
backcrossed and were maintained on a pure C57Bl/6 background. C57Bl/6
mice were used to determine expression of Hh pathway components during
different stages of epidermal development.
The TEWL of newborn mice was examined with the use of a Tewameter
(Courage+Khazaka Electronic) as described by Barel and Clarys (1995).
Mouse experiments were performed according to institutional guidelines
and the animal license given by the State Office of North Rhine-Westphalia,
Germany.
The institutional review board of the Medical Faculty of the University of
Cologne approved the use of human tumor tissues in this study. Written
informed consent was obtained from patients in accordance with the guide-
lines and policies of the review board.
Tumor Experiments
The formation of sebaceous tumors was induced in 9-week-old K14DNLef1/
IhhEKO (n = 19) and K14DNLef1/Ihhfl/fl mice (n = 17) as described previously
(Niemann et al., 2007). Briefly, mice of both genotypes were treated with asingle subthreshold dose of DMBA (100 nmol; Sigma-Aldrich). Alternatively,
mice received acetone vehicle as a treatment control (n = 9). Generally, seba-
ceous tumors developed 4–5 weeks following DMBA application, and scoring
of tumors was carried out once a week for up to 25 weeks after DMBA
treatment.
In one setting, sebaceous tumors generated in K14DNLef1 transgenic mice
were treated daily with cyclopamine (60 nmol; Sigma Aldrich) or control vehicle
for three consecutive days according to previous protocols (Silva-Vargas et al.,
2005) and the size of the tumors was measured every day.
To induce squamous papillomas and SCCs, 9-week-old IhhEKO (n = 20) and
Ihhfl/fl mice (n = 19) received a topical subthreshold dose of DMBA once
(100 nmol in acetone) followed by repetitive application of the tumor promoter
TPA (6 nmol in acetone; LC Laboratories). TPA treatment was done thrice per
week for up to 25 weeks. Mice of control groups (n = 14) were treated with
DMBA and acetone, acetone and TPA, or acetone alone. Scoring and mea-
surement of tumors were done once per week and mice were monitored for
up to 50 weeks following DMBA application. Tumor size was calculated by
measuring the length and width of tumors once per week. Both tumor studies
were done twice and gave similar results.
Histological Analysis and Immunofluorescent Stainings
The mice were sacrificed and tail and back skin, epidermal whole mounts, or
tumors were harvested according to standard protocols (Braun et al., 2003).
Tissue was analyzed from at least three mice per genotype and experiment.
For LRC studies, pups received four injections of BrdU (50 mg/kg body
weight; Sigma-Aldrich) at 12 hr intervals. To analyze the LRCs, mice were
sacrificed at 7 weeks of age and epidermal whole mounts were prepared
as previously described (Braun et al., 2003). To examine cell proliferation
in epidermis and tumors, mice were injected intraperitoneally with BrdU
(100 mg/kg body weight; Sigma-Aldrich) 1 hr before they were sacrificed.
Tissue was embedded into OCT (Sakura) or paraffin following fixation with
4% formaldehyde.
To quantify cell proliferation within SCCs, tumor areas that had a suprabasal
localization of BrdU-positive nuclei and were clearly distinct from benign
papilloma structures were counted.
The following antibodies were used to stain tissue sections: K14 (1:1,000;
Covance), K5 (1:1,000; Covance), K6a (1:600, Covance), K10 (1:250, Cova-
nce), K15 (1:250; Neomarkers), SCD1 (1:100; Santa Cruz), adipophilin
(1:1,000; Fitzgerald Industries), filaggrin (1:1,000; Covance), BrdU (1:10; BD),
CD34 (1:100; e-Bioscience), Sox9 (1:750, kindly provided by M. Wegner [Stolt
et al., 2003]), Lrig1 (1:100; R&D), Plet1 (1:5, kindly provided by A. Sonnenberg
[Raymond et al., 2010]), integrina6 (1:3,000; BD PharMingen), and laminin sub-
unit a-5 (1:500, kindly provided by L. Sorokin [Sorokin et al., 1997]). Secondary
antibodies were coupled to Alexa-488 and Alexa-594 (1:1,000; Invitrogen) and
applied together with propidium iodide or DAPI (Sigma-Aldrich) to counterstain
nuclei. Images were acquired with a Nikon eclips-E800, Olympus U-TB190, or
Leica DM 4000B and analyzed with ImageJ software.
Lipid Analysis
Lipids of the stratum corneum and the sebaceous glands were measured as
described previously (Reichelt et al., 2004; Fehrenschild et al., 2012).
Statistical Analysis
Statistical analysis of differences in tumor frequency was carried out using
two-way ANOVA with repeated measures. Data sets were analyzed for statis-
tical significance using a two-tailed unpaired Student’s t test. All p values
below 0.05 were considered significant. All statistical analyses were done
using Microsoft Exel, GraphPad Prism 5, and SPSS Version 7.
Additional details regarding the experimental procedures can be found in
the Extended Experimental Procedures and Tables S1 and S2.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at http://dx.
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